News & Press Release
Click here for a list of past News
Kumiko Nishihara moved to Department of Clinical Research Support.
October 2022 to July 2025 We started the following clinical trial “A phase 1 first in human study evaluating safety, pharmacokinetics and efficacy of ABBV-400 in adult subjects with adult subjects with advanced solid tumors”
September 2022 to May 2025 We started the following clinical trial “A study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors”
August to December 2022 We started the following clinical trial “An Open-Label, Dose Escalation, Phase 1, First-in Human Study of TAK-102 in Adult Patients with GPC3-Expressing Previously Treated Solid Tumors”
“Study on age-related changes in human immunocompetent cells” (new research on new coronavirus vaccine) has started.